Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates E Papapoulos

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Bone|February 28, 2012
Acute phase response following intravenous zoledronate in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
The Journal of Rheumatology|September 1, 2004
Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritisSerge C L M Cremers, Mariëtte C Lodder, Jan Den Hartigh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeletonVidya Soerdjbalie-Maikoe, Rob C M Pelger, Guus A B Lycklama à Nijeholt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastasesSerge C L M Cremers, Socrates E Papapoulos, Hans Gelderblom, et al.
Cancer Research|September 6, 2005
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivoGabri van der Pluijm, Ivo Que, Bianca Sijmons, et al.
Bone|August 27, 2019
Familial Paget's disease of bone: Long-term follow-up of unaffected relatives with and without Sequestosome 1 mutationsJoséphine J M Peeters, Raphaël De Ridder, Esther C Hamoen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2004
Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancerVidija Soerdjbalie-Maikoe, Rob C M Pelger, Guus A B Lycklama à Nijeholt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2002
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal miceMartine M L Deckers, Ermond R Van Beek, Gabri Van Der Pluijm, et al.
Bone|December 25, 2025
Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS)Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
BMJ Oncology|December 1, 2025
Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trialsMaria P Yavropoulou, Dimitrios A Anastasilakis, Maria-Iosifina Kasdagli, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Bone|February 28, 2012
Acute phase response following intravenous zoledronate in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
The Journal of Rheumatology|September 1, 2004
Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritisSerge C L M Cremers, Mariëtte C Lodder, Jan Den Hartigh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeletonVidya Soerdjbalie-Maikoe, Rob C M Pelger, Guus A B Lycklama à Nijeholt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastasesSerge C L M Cremers, Socrates E Papapoulos, Hans Gelderblom, et al.
Cancer Research|September 6, 2005
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivoGabri van der Pluijm, Ivo Que, Bianca Sijmons, et al.
Bone|August 27, 2019
Familial Paget's disease of bone: Long-term follow-up of unaffected relatives with and without Sequestosome 1 mutationsJoséphine J M Peeters, Raphaël De Ridder, Esther C Hamoen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2004
Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancerVidija Soerdjbalie-Maikoe, Rob C M Pelger, Guus A B Lycklama à Nijeholt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2002
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal miceMartine M L Deckers, Ermond R Van Beek, Gabri Van Der Pluijm, et al.
Bone|December 25, 2025
Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS)Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
BMJ Oncology|December 1, 2025
Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trialsMaria P Yavropoulou, Dimitrios A Anastasilakis, Maria-Iosifina Kasdagli, et al.
Pageof 8